SciELO - Scientific Electronic Library Online

 
vol.5 número4La hiperreactividad cardiovascular y su asociación con factores de riesgo cardiovasculares índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Finlay

versión On-line ISSN 2221-2434

Resumen

VALIENTE MOREJóN, Wilfredo et al. Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma. Rev. Finlay [online]. 2015, vol.5, n.4, pp. 221-227. ISSN 2221-2434.

Background: prostatic neoplasms remain asymptomatic for several years and are the second leading cause of morbidity and mortality among men over 50 years. Objective: to identify the presence of prostate adenocarcinoma through prostate-specific antigen screening in men older than 50 years. Method: a descriptive study was carried out in Consolación del Sur from January 2011 through September 2013. The universe consisted of all men (3155) aged 50 and older who underwent the test in this municipality. A survey was conducted to obtain information related to age, skin color, prostate-specific antigen results, indication for the test and year it was performed. Statistical data processing was executed using absolute frequencies, percentages and averages. Results: the screening covered 21.8 % of the population and yet 17 new cases were diagnosed. Patients aged 80 years and over predominated. The test that identifies patients at risk for prostate adenocarcinoma showed a low percentage of positivity (0.5 %). Urology specialists established more diagnosis than all family physicians in the municipality. Conclusions: the prostate-specific antigen is a useful test for the diagnosis of prostate adenocarcinoma. For that reason, it should be used as routine examination in all men older than 50 years in patients suspected of having this condition.

Palabras clave : prostate-specific antigen; predictive value of tests; reference values; diagnosis; adenocarcinoma; prostatic neoplasms.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License